Désiré Collen - Concepedia

Author

Désiré Collen

Also Known As

D Collen, D. Collen, DESIRE COLLEN, Desire Collen, Desiré Collen, Désiré Collen, DÉSIRÉ COLLEN, Désiré Collen, H. R. Lijnen

198

Publications

15.4K

Citations

H-Index

161

Concepts

All Affiliations

KU Leuven Vlaams Instituut voor Biotechnologie VIB-KU Leuven Center for Cancer Biology Massachusetts General Hospital Sanofi (France)

About

Désiré Collen is an author at KU Leuven specializing in medicine, cell biology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	44	57	9.9K
2	Health Sciences	9	9	937
3	Natural Sciences	5	5	585
4	Engineering	4	4	825
5	Public Health	2	2	356

Désiré Collen

Publications

14.2K

Citations

H-Index

Page 1

	Year	Citations
Targeted Deficiency or Cytosolic Truncation of the VE-cadherin Gene in Mice Impairs VEGF-Mediated Endothelial Survival and Angiogenesis Peter Carmeliet, Maria Grazia Lampugnani, Lieve Moons, Cell AngiogenesisImmunologyEndothelial DysfunctionVe-cadherin GeneVascular Biology	1999	1.3K
Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration Bert Oosthuyse, Lieve Moons, Erik Storkebaum, Nature Genetics Neurodegenerative DiseasesMotor Neuron DegenerationHypoxia-response ElementHypoxia (Medicine)Endothelial Dysfunction	2001	1K
Oxidized LDL and Malondialdehyde-Modified LDL in Patients With Acute Coronary Syndromes and Stable Coronary Artery Disease Paul Holvoet, Johan Vanhaecke, S. Janssens, Circulation	1998	671
Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formation Peter Carmeliet, Lieve Moons, Roger Lijnen, Nature Genetics InflammationUrokinase-generated PlasminMetalloproteinEndothelial DysfunctionVascular Biology	1997	660
Total inactivation of γ–secretase activity in presenilin-deficient embryonic stem cells An Herreman, Lutgarde Serneels, Wim Annaert, Nature Cell Biology Embryonic Stem CellDevelopmental BiologyMedicineNatural SciencesNeural Stem Cell	2000	481
Impaired angiogenesis and endochondral bone formation in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188 Christa Maes, Peter Carmeliet, Karen Moermans, Mechanisms of Development Developmental BiologyAngiogenesisBone Morphogenic ProteinImpaired AngiogenesisVascular Biology	2002	452
Fibrinolytic properties of one-chain and two-chain human extrinsic (tissue-type) plasminogen activator. D.C. Rijken, Marc Hoylaerts, Désiré Collen Journal of Biological Chemistry EngineeringBiomedical ResearchCell CultureCytoskeletonBiomedical Engineering	1982	419
Plasminogen activator inhibitor-1 gene-deficient mice. II. Effects on hemostasis, thrombosis, and thrombolysis. Peter Carmeliet, J M Stassen, Luc Schoonjans, Journal of Clinical Investigation ImmunologyPharmacotherapyInflammationThrombosisHematology	1993	390
Plasminogen activator inhibitor-1 gene-deficient mice. I. Generation by homologous recombination and characterization. Peter Carmeliet, L Kieckens, Luc Schoonjans, Journal of Clinical Investigation Knockout MouseImmunogeneticsSystems BiologyProtein ExpressionPlasma Pai-1 Levels	1993	349
Nucleotide sequence of the partially deleted D4Z4 locus in a patient with FSHD identifies a putative gene within each 3.3 kb element Jan Gabriëls, M.-C. Beckers, Hao Ding, Gene Developmental BiologyMendelian DisorderPutative GeneGenetic DisorderGenetics	1999	342

Page 1